Clinical Trials Browser

Genital Diseases, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT03490032 2020-11-17

PROfind

Phase 1/2 Completed

30 enrolled 30 charts

Genitourinary

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT02606123 2018-03-01

Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 1/2 Terminated

28 enrolled

Genitourinary

Genital Diseases, Male, Genital Neoplasms, Male, Prostatic Diseases, Prostatic Neoplasms

NCT00895466 2009-05-08

Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients

Phase 1/2 Unknown

12 enrolled

Genitourinary

Neoplasms, Prostatic Diseases, Prostatic Neoplasms

Clinical Trials

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

P300

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer

PROfind

Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer

Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients